US 8361710
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21
granted A61PA61P35/00
Quick answer
US patent 8361710 (MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00